biOasis Technologies Inc (BTI)

0.2800
+0.0050(+1.82%)
  • Volume:
    30,000
  • Bid/Ask:
    0.2750/0.2800
  • Day's Range:
    0.2800 - 0.2800
  • Type:Equity
  • Market:Canada
  • ISIN:CA09064N1033
  • CUSIP:09064N103

BTI Overview

Prev. Close
0.275
Day's Range
0.28-0.28
Revenue
-
Open
0.28
52 wk Range
0.23-0.7
EPS
-0.02
Volume
30,000
Market Cap
19.84M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
35,685
P/E Ratio
-
Beta
0.33
1-Year Change
-19.12%
Shares Outstanding
72,144,015
Next Earnings Date
Jan. 26, 2022
What is your sentiment on biOasis Technologies Inc?
or
Vote to see community's results!

biOasis Technologies Inc Company Profile

Employees
0
Market
Canada

Bioasis Technologies Inc., a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the delivery of therapeutics across the blood-brain barrier (BBB); and the treatment of central nervous system disorders, including brain cancers, and metabolic and neurodegenerative diseases. The company’s in-house development programs develop symptomatic and disease-modifying treatments for brain metastases (xB3-001), glioblastoma (xB3-002), and neurodegenerative diseases (xB3-007). Bioasis Technologies Inc. has research collaborations with Aposense Limited to focus on the delivery of siRNA into the brain; and Oxyrane UK Ltd. to focus on combining xB3 technology and Oxyrane’s OxyCAT platform to deliver an undisclosed enhanced enzyme replacement therapy into the brain. The company was incorporated in 2006 and is headquartered in New Haven, Connecticut.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellStrong SellSell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellSell
SummaryStrong SellStrong SellStrong SellStrong SellSell
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.